Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy — Stella

Home/Central Serous Chorioretinopathy/Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy

View on ClinicalTrials.gov

Recruiting

Back to Central Serous Chorioretinopathy trials

Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Australia

Centre for Eye Research Australia, East Melbourne, Victoria

Retinology Institute, Glen Iris, Victoria

Key details

Sponsor

Nova Eye Medical Pty Ltd.

Collaborators

Center for Eye Research Australia

Enrollment target

~60 participants

Started

October 2022

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.